THERAPY OF ADVANCED BLADDER CANCER BY TARGETING HYAL2 WITH ANTIBODY-DRUG CONJUGATE: PRECLINICAL STUDY

被引：0
|
作者：
O'Malley, Padraic
Donelan, William
Hsieh, Meng-Lun
Li, Shiwu
Nguyen, Brianna
Crispen, Paul
Kusmartsev, Sergei
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP65-19
引用
收藏
页码：E1084 / E1084
页数：1
相关论文
共 50 条
  • [31] Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer
    Bosco, Emily E.
    Christie, Ronald J.
    Carrasco, Rosa
    Sabol, Darrin
    Zha, Jiping
    DaCosta, Karma
    Brown, Lee
    Phipps, Sandrina
    Du, Qun
    Bezabeh, Binyam
    Breen, Shannon
    Chen, Cui
    Reed, Molly
    Hinrichs, MaryJane
    Zhong, Haihong
    Xiao, Zhan
    Dixit, Rakesh
    Herbst, Ronald
    Tice, David A.
    CANCER RESEARCH, 2018, 78 (13)
  • [32] MONOCLONAL ANTIBODY-DRUG CONJUGATE THERAPY FOR THE PATIENTS WITH COLORECTAL-CANCER
    TAKAHASHI, T
    YAMAGUCHI, T
    KITAMURA, K
    NOGUCHI, A
    HONDA, M
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 168 (02): : 371 - 374
  • [33] Development of an antibody-drug conjugate against tissue factor for cancer therapy
    Tsumura, Ryo
    Anzai, Takahiro
    Takashima, Hiroki
    Koga, Yoshikatsu
    Matsumura, Yasuhiro
    Yasunaga, Masahiro
    CANCER SCIENCE, 2024, 115 : 617 - 617
  • [34] Evaluation of the DLL3-targeting Antibody-Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma
    Krytska, Kateryna
    Casey, Colleen E.
    Pogoriler, Jennifer
    Martinez, Daniel
    Rathi, Komal S.
    Farrel, Alvin
    Berko, Esther R.
    Tsang, Matthew
    Sano, Renata R.
    Kendsersky, Nathan
    Erickson, Stephen W.
    Teicher, Beverly A.
    Isse, Kumiko
    Saunders, Laura
    Smith, Malcolm A.
    Maris, John M.
    Mosse, Yael P.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (07): : 616 - 623
  • [35] Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET
    van Scheltinga, Anton G. T. Terwisscha
    Ogasawara, Annie
    Pacheco, Glenn
    Vanderbilt, Alexander N.
    Tinianow, Jeff N.
    Gupta, Nidhi
    Li, Dongwei
    Firestein, Ron
    Marik, Jan
    Scales, Suzie J.
    Williams, Simon-Peter
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (01) : 134 - 142
  • [36] Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate
    Yang, Ming-Chen
    Shia, Chi-Sheng
    Li, Wan-Fen
    Wang, Chun-Chung
    Chen, I-Ju
    Huang, Teng-Yi
    Chen, Yu-Jung
    Chang, Hui-Wen
    Lu, Chi-Huan
    Wu, Yueh-Chin
    Wang, Nan-Hsuan
    Lai, Jiann-Shiun
    Yu, Cheng-Der
    Lai, Ming-Tain
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (06) : 1121 - 1132
  • [37] Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma
    Tu, Jianghua
    Toh, Yukimatsu
    Aldana, Adela M.
    Wen, Jake J.
    Wu, Ling
    Jacob, Joan
    Li, Li
    Pan, Sheng
    Carmon, Kendra S.
    Liu, Qingyun J.
    PHARMACEUTICS, 2024, 16 (07)
  • [38] A phase II study of glembatumumab vedotin (GV), an antibody-drug conjugate (ADC) targeting gpNMB, in advanced melanoma
    Ott, Patrick Alexander
    Pavlick, Anna C.
    Johnson, Douglas Buckner
    Hart, Lowell L.
    Infante, Jeffrey R.
    Luke, Jason John
    Lutzky, Jose
    Rothschild, Neal Evan
    Spitler, Lynn E.
    Cowey, Charles Lance
    Alizadeh, Aaron
    Salama, April K.
    Yin, Xiaoyan
    Bagley, Rebecca G.
    Wang, Ying
    Hamid, Omid
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Preclinical development of a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
    Son, Thomas
    Scribner, Juniper A.
    Hooley, Jeff
    Chiechi, Michael
    Li, Pam
    Hotaling, Timothy E.
    De Costa, Anushka
    Chen, Yan
    Chen, Francine
    Barat, Bhaswati
    Ciccarone, Valentina
    Gaynutdinov, Timur
    Tamura, James
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2017, 77
  • [40] Activity of antibody-drug conjugates (ADCs) with radiation in preclinical bladder cancer models.
    D'Andrea, Vincent
    Zhou, Yuzhen
    Shanmugam, Surish
    Chroneos, Rea
    Stelter, Isabella
    Hanlon, Timothy
    Bekele, Raie
    Anderson, William
    Carvalho, Filipe L. F.
    Bellmunt, Joaquim
    Mouw, Kent William
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 664 - 664
12345